Arrhythmogenic Right Ventricular Dysplasia

Test cost: $3390
This test is currently only available in BHS CPRS. If you are a Bedford provider and wish to see this test offered in Bedford CPRS- please contact the Bedford Laboratory.

ARVC PANEL(O)

Arrhythmogenic Righ Ventricular Cardiomyopathy
ARVC

Purple top tube, whole blood

2-5mL

Refrigerated: 7 days

10 weeks

Provided with the patient report in CPRS.

Arrhythmogenic right ventricular cardiomyopathy (ARVC), also known as arrhythmogenic right ventricular dysplasia (ARVD), is a potentially life-threatening heart muscle disease that can cause sudden cardiac death in young persons and athletes. ARVC is a disorder of the cardiac desmosome – protein complexes that maintain cell-to-cell connections and provide mechanical attachments among adjacent cells. Myocyte death and replacement by fat and fibrous tissue in the right ventricle are the pathologic hallmarks of the disease, which may predispose to ventricular tachyarrhythmia and sudden cardiac death. The disease prevalence is estimated at 1:1000 to 1:2500, but may be higher in certain populations and because of non-diagnosed or misdiagnosed cases. Patients with ARVC typically develop symptoms between the second and fifth decade of life (mean age at diagnosis 31 years), however onset and severity are widely variable.